Karyopharm Therapeutics reported $8K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acceleron Pharma XLRN:US $ 0.06M 0M
Amgen AMGN:US $ 31877M 71M
AstraZeneca AZN:LN 328M 0M
Astrazeneca AZN:US $ 328M 0M
Avrobio Inc AVRO:US $ 4K 0
Bristol Myers Squibb BMY:US $ 292M 0M
Eli Lilly And LLY:US $ 598.1M 1.6M
Epizyme EPZM:US $ 0.01M 0M
GlaxoSmithKline GSK:LN 1347M 1M
Karyopharm Therapeutics KPTI:US $ 8K 0
Macrogenics MGNX:US $ 0.6M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Nektar Therapeutics NKTR:US $ 0.02M 0M
Novartis NOVN:VX SF 913M 0M
Novartis NVS:US $ 913M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sangamo Biosciences SGMO:US $ 1.45M 0.01M
Takeda 4502:JP Y 1669125M 980M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Xencor XNCR:US $ 0.58M 0M
YTE INCY:US $ 0.22M 0M